Business Description
Geratherm Medical AG
ISIN : DE0005495626
Description
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.34 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 2.29 | |||||
| Interest Coverage | 17.05 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.23 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7 | |||||
| 3-Year EBITDA Growth Rate | 6.2 | |||||
| 3-Year EPS without NRI Growth Rate | 50.4 | |||||
| 3-Year Book Growth Rate | 0.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.89 | |||||
| 9-Day RSI | 34.64 | |||||
| 14-Day RSI | 33.93 | |||||
| 6-1 Month Momentum % | -23.54 | |||||
| 12-1 Month Momentum % | -42.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.99 | |||||
| Quick Ratio | 9.52 | |||||
| Cash Ratio | 6.47 | |||||
| Days Inventory | 303.45 | |||||
| Days Sales Outstanding | 47.03 | |||||
| Days Payable | 51.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.69 | |||||
| Dividend Payout Ratio | 0.62 | |||||
| 3-Year Dividend Growth Rate | -33.1 | |||||
| Forward Dividend Yield % | 3.69 | |||||
| 5-Year Yield-on-Cost % | 1.16 | |||||
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | 5.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.16 | |||||
| Operating Margin % | 11.12 | |||||
| Net Margin % | 3.73 | |||||
| FCF Margin % | 0.17 | |||||
| ROE % | 4.51 | |||||
| ROA % | 2.59 | |||||
| ROIC % | 7.21 | |||||
| ROC (Joel Greenblatt) % | 9.99 | |||||
| ROCE % | 5.74 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.03 | |||||
| PE Ratio without NRI | 21.03 | |||||
| PEG Ratio | 3.69 | |||||
| PS Ratio | 0.81 | |||||
| PB Ratio | 0.97 | |||||
| Price-to-Tangible-Book | 1.19 | |||||
| Price-to-Free-Cash-Flow | 156.92 | |||||
| Price-to-Operating-Cash-Flow | 7.56 | |||||
| EV-to-EBIT | 10.07 | |||||
| EV-to-EBITDA | 5.43 | |||||
| EV-to-Revenue | 0.7 | |||||
| EV-to-FCF | 421.67 | |||||
| Price-to-Projected-FCF | 1.59 | |||||
| Price-to-Median-PS-Value | 0.74 | |||||
| Price-to-Graham-Number | 1.44 | |||||
| Price-to-Net-Current-Asset-Value | 2.69 | |||||
| Earnings Yield (Greenblatt) % | 9.93 | |||||
| FCF Yield % | 0.21 | |||||
| Forward Rate of Return (Yacktman) % | -0.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Geratherm Medical AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 27.44 | ||
| EPS (TTM) (€) | 0.194 | ||
| Beta | 0.42 | ||
| Volatility % | 30.71 | ||
| 14-Day RSI | 33.93 | ||
| 14-Day ATR (€) | 0.118922 | ||
| 20-Day SMA (€) | 4.213 | ||
| 12-1 Month Momentum % | -42.4 | ||
| 52-Week Range (€) | 3.7 - 7.6 | ||
| Shares Outstanding (Mil) | 5.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Geratherm Medical AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Geratherm Medical AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Geratherm Medical AG Frequently Asked Questions
What is Geratherm Medical AG(XTER:GME)'s stock price today?
The current price of XTER:GME is €4.06. The 52 week high of XTER:GME is €7.60 and 52 week low is €3.70.
When is next earnings date of Geratherm Medical AG(XTER:GME)?
The next earnings date of Geratherm Medical AG(XTER:GME) is .
Does Geratherm Medical AG(XTER:GME) pay dividends? If so, how much?
The Dividend Yield %  of Geratherm Medical AG(XTER:GME) is 3.69% (As of Today), Highest Dividend Payout Ratio of Geratherm Medical AG(XTER:GME) was 10.26. The lowest was 0.43. And the median was 1.7. The  Forward Dividend Yield % of Geratherm Medical AG(XTER:GME) is 3.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers